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Introduction: Gestational trophoblastic tumours are a rare form of malignancy, which in the majority of cases arise
from abnormal trophoblast cells formed in a complete molar pregnancy. These tumours are extremely sensitive to
chemotherapy and high cure rates approaching 100% can be expected. The disease is usually limited to the uterus
where the abnormal trophoblast proliferation and human chorionic production can lead to vascular changes
including the formation of arteriovenous malformations.
Case presentation: We describe the case of a 28-year-old Caucasian woman who presented to the United
Kingdom's Gestational Trophoblast Tumour Service with rising human chorionic gonadotropin levels following a
uterine evacuation for a complete molar pregnancy. She was commenced on chemotherapy but subsequently
reported two episodes of haemoptysis. Computed tomography imaging demonstrated findings consistent with a
pulmonary arteriovenous malformation, probably due to a small pulmonary metastasis, complicated by recent
haemorrhage. These findings were confirmed on emergency pulmonary arteriography, and the pulmonary
arteriovenous malformation was successfully embolised.
Conclusions: Arteriovenous malformations secondary to gestational trophoblastic tumours at metastatic sites have
only been reported in a very limited number of cases. When significant bleeding occurs, as in this case of a
pulmonary lesion, urgent referral for embolisation is indicated.
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Gestational trophoblastic tumours (GTT) are character-
istically highly vascular and can produce heavy or even
life-threatening bleeding from the uterus or sites of
metastatic disease [1]. Over 90% of cases of GTT result
from the continual growth of the abnormal trophoblast
cells that are formed in a complete molar pregnancy.
Molar pregnancies are rare and occur at a rate of ap-
proximately one for every 600 conceptions and carry
an approximate risk of malignant change of 14% for
complete moles and 1% for partial moles [2].* Correspondence: Philip.Savage@bccancer.bc.ca
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share many of the characteristics of healthy trophoblast
cells, including human chorionic gonadotropin (hCG)
production, rapid division, the ability to invade surround-
ing tissues and to stimulate angiogenesis and other vascu-
lar changes. Fortunately gestational trophoblast tumours
are extremely sensitive to chemotherapy and modern cure
rates approaching 100% can be expected for patients who
develop GTTafter a molar pregnancy [3].
In the majority of GTT cases the disease is limited to the
uterus where the abnormal trophoblast proliferation and
localised hCG production may lead to focal vascular
changes including the formation of arteriovenous malfor-
mations (AVMs) [4,5]. The development of uterine AVMsed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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are asymptomatic, some can lead to life-threatening bleed-
ing requiring treatment with hysterectomy or radiological
embolisation [1].
The most common site of metastasis in GTT are the
lungs, but the formation of AVMs at this or any other
extra-uterine site of spread has only been recorded
rarely [6,7]. This case reviews the diagnosis of a pulmon-
ary AVM (pAVM) in a patient with GTT and occult lung
metastases successfully treated with radiological embol-
isation and chemotherapy.Figure 2 Selective left pulmonary artery branch angiogram
demonstrates rapid arteriovenous shunting through the
pulmonary arteriovenous malformation.Case presentation
A 28-year-old Caucasian woman underwent a uterine
evacuation for a molar pregnancy at her local hospital and
was registered for follow up with the United Kingdom
(UK) Gestational Trophoblast Tumour service. The histo-
pathology review confirmed the diagnosis of a complete
molar pregnancy and as such she was enrolled in the hCG
surveillance programme. After an initial early fall in her
serum hCG level, her hCG level rose in two consecutive
samples, because of this she was reviewed in clinic 14
weeks post-evacuation prior to consideration of chemo-
therapy treatment.
She had an unremarkable medical history, with two
normal pregnancies, no major surgery or illnesses and
no regular medications. The routine investigations dem-
onstrated an hCG value of 2070IU/L, a normal chest X-
ray and no visible uterine mass on the pelvic DopplerFigure 1 Axial computed tomography image at level of aortic
root demonstrates small left lower lobe pulmonary
arteriovenous malformation (arrow) with surrounding ground
glass opacity consistent with recent haemorrhage.ultrasound but some increased vascularity. These results
confirmed the indications for treatment and produced
an International Federation of Gynecology and Obstet-
rics (FIGO) prognostic score of 1. Following the UK’s
standard treatment protocols, chemotherapy treatment
was commenced with the low-risk regimen of metho-
trexate and folinic acid [3].
The patient was well 6 weeks after the commencement
of chemotherapy but reported two modest episodes of
haemoptysis and was readmitted for emergencyFigure 3 Postembolization pulmonary arteriogram
demonstrates complete occlusion of the pulmonary
arteriovenous malformation.
Figure 4 Axial computed tomography image at same level as
Figure 1 performed 4 years after embolization shows metallic
coils and obliteration of pulmonary arteriovenous
malformation (arrow).
McDonald-Burrows et al. Journal of Medical Case Reports 2014, 8:117 Page 3 of 4
http://www.jmedicalcasereports.com/content/8/1/117investigation. Initial blood tests confirmed a normal
clotting screen and platelet count, whereas a computed
tomography (CT) scan of her thorax demonstrated a
17mm lobulated nodule in the apical segment of her left
lower lobe. Surrounding this lesion, there was patchy
ground glass opacification consistent with pulmonary
haemorrhage (Figure 1). The CT findings were typical
of a pAVM, probably due to a small pulmonary metasta-
sis, complicated by recent haemorrhage.Figure 5 Patient human chorionic gonadotropin levels during course
treatment was changed to the etoposide, methotrexate and dactinomycin
chorionic gonadotropin levels normalised 3 weeks subsequent to this chan
etoposide, methotrexate and dactinomycin; HCG(S), human chorionic gonaAn urgent referral was made to the interventional
radiology team and emergency pulmonary arteriography
confirmed the presence of a pAVM (Figure 2) with two
separate feeding vessels. The pAVM was successfully
embolised with magnetic resonance-compatible coils as
shown in Figure 3 and led to resolution of the haemop-
tysis. A follow-up thoracic CT 4 years after embolisation
confirmed that the pAVM had been cured as shown in
Figure 4.
Just prior to the embolisation procedure, her chemo-
therapy treatment had been changed to the etoposide,
methotrexate and dactinomycin alternating with cyclo-
phosphamide and vincristine regime as a result of a slow
rate of hCG fall with methotrexate. Subsequent to this
change, her hCG levels normalised 3 weeks later and
after an additional 6 weeks of treatment chemotherapy
was completed as shown in Figure 5. She remains well 4
years later, is cured of her tumour, has gone on to have
another healthy baby and has had no further episodes of
haemoptysis.
Discussion
Gestational trophoblast tumours are a rare but highly cur-
able form of malignancy. The majority of cases occur as a
result of a complete molar pregnancy and are characterised
as hCG producing, highly vascular and chemosensitive tu-
mours. The effect of the tumour-derived hCG on angio-
genesis is well documented [4,5] and AVMs in the uterus
are a relatively frequent event and generally simple to man-
age with uterine artery embolisation for cases with heavy
or persistent bleeding [1].of treatment. Levels fell at a slow rate with methotrexate and
alternating with cyclophosphamide and vincristine regime. The human
ge. Abbreviations: CO, cyclophosphamide and vincristine; EMA,
dotropin.
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highly vascular and have the potential to form AVMs that
can lead to life-threatening haemorrhage [6,7]. In this
current case a patient with low-risk post-molar pregnancy
GTT developed haemoptysis during methotrexate chemo-
therapy and imaging investigations demonstrated an AVM
in her left lung. The most probable cause was that this
was as a result of a small GTT metastasis that was too
small to be visualised on the initial screening chest X-ray.
The presentation, timing and clinical findings were con-
sistent with this being a GTT-related AVM rather than
other aetiology. The vast majority of pAVMs occur in
patients with hereditary haemorrhagic telangiectasia in
whom they are usually multiple. In this patient there was
no family history or clinical evidence of this condition, in
addition, no other pAVMs were present in either lung.
In uterine AVMs with light to moderate bleeding, the
usual management is to manage these expectantly as
many resolve spontaneously with successful chemother-
apy treatment. However, in this case with a pulmonary
lesion and the potential for life-threatening bleeding, we
elected to control the bleeding risk promptly by per-
forming the embolisation.
In the UK the management of patients with post-
molar pregnancy GTT is centralised, which has allowed
the development of expertise in these rare cases. From
the almost 3000 other patients treated previously, no
cases of bleeding from pAVMs have been recorded. As a
result the FIGO recommendation of a chest X-ray re-
mains the appropriate investigation for assessment of
potential lung metastases in these patients [8]. Clearly if
haemoptysis occurs, as in this rare case, then more de-
tailed assessment with CT is indicated.Conclusions
Although we appreciate that pAVMs secondary to meta-
static GTT are extremely rare, it is clear from this report
that they are at risk of rupture causing haemoptysis. When
diagnosed, we suggest that urgent referral for embolisation
should be considered to reduce the risk of bleeding.Consent
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